Sen. Wyden, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
March 04, 2022
March 04, 2022
WASHINGTON, March 4 -- Sen. Ron Wyden, D-Oregon, issued the following news release:
U.S. Senator Ron Wyden joined colleagues today in expressing concern over findings from two new analyses that reveal troubling, widespread, and rapid price increases for brand name drugs in January 2022.
"The large, across-the-board price increases of popular, brand name prescription drugs appear to be an example of pharmaceutical companies taking advantage of their abusive market p . . .
U.S. Senator Ron Wyden joined colleagues today in expressing concern over findings from two new analyses that reveal troubling, widespread, and rapid price increases for brand name drugs in January 2022.
"The large, across-the-board price increases of popular, brand name prescription drugs appear to be an example of pharmaceutical companies taking advantage of their abusive market p . . .